Prime Medicine, Inc. (PRME)
3.815
+0.14
(+3.95%)
USD |
NASDAQ |
Apr 17, 15:24
Prime Medicine Total Liabilities (Quarterly) : 495.77M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 161.76M |
| Lineage Cell Therapeutics, Inc. | 69.24M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Agenus, Inc. | 504.66M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 616.64M |
| Shareholders Equity (Quarterly) | 120.87M |
| Debt to Equity Ratio | 0.9633 |
| Current Ratio | 4.841 |
| Net Debt Paydown Yield | -2.40% |